Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cytokinetics, Incorporated(CYTK) | 360,000 | 370,000 | +10,000 | $16.93M | $14.87M | 8.08% | -$2.06M |
| Kalvista Pharmaceuticals Inc | 1,787,003 | 1,014,367 | -772,636 | $15.14M | $11.71M | 6.36% | -$3.43M |
| Evolus, Inc.(EOLS) | 895,524 | 944,743 | +49,219 | $9.89M | $11.37M | 6.18% | +$1.48M |
| ABIVAX Société AnonymeADS(ABVX) | 1,648,523 | 1,638,111 | -10,412 | $12.07M | $10.24M | 5.57% | -$1.83M |
| Viridian Therapeutics, Inc.(VRDN) | 750,000 | 750,000 | 0 | $14.38M | $10.11M | 5.50% | -$4.27M |
| Merus N V | 158,092 | 237,156 | +79,064 | $6.65M | $9.98M | 5.43% | +$3.33M |
| Akebia Therapeutics, Inc.(AKBA) | 0 | 4,973,840 | +4,973,840 | $0 | $9.55M | 5.19% | +$9.55M |
| Xenon Pharmaceuticals Inc.(XENE) | 245,272 | 245,272 | 0 | $9.61M | $8.23M | 4.47% | -$1.39M |
| Ascendis Pharma A/SADR(ASND) | 0 | 50,000 | +50,000 | $0 | $7.79M | 4.24% | +$7.79M |
| Dynavax Technologies Corp | 860,000 | 595,879 | -264,121 | $10.98M | $7.73M | 4.20% | -$3.25M |
| Ionis Pharmaceuticals, Inc.(IONS) | 505,007 | 250,000 | -255,007 | $17.66M | $7.54M | 4.10% | -$10.11M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 0 | 1,811,996 | +1,811,996 | $0 | $6.41M | 3.49% | +$6.41M |
| Immunovant, Inc.(IMVT) | 0 | 375,000 | +375,000 | $0 | $6.41M | 3.48% | +$6.41M |
| Unicycive Therapeutics Inc | 10,980,000 | 10,980,000 | 0 | $8.72M | $6.31M | 3.43% | -$2.41M |
| Neurogene Inc.(NGNE) | 442,761 | 470,964 | +28,203 | $10.12M | $5.51M | 3.00% | -$4.61M |
| Dianthus Therapeutics, Inc.(DNTH) | 275,000 | 275,000 | 0 | $6.00M | $4.99M | 2.71% | -$1.01M |
| Legend Biotech CorporationADS(LEGN) | 0 | 138,240 | +138,240 | $0 | $4.69M | 2.55% | +$4.69M |
| Vaxcyte, Inc.(PCVX) | 0 | 115,517 | +115,517 | $0 | $4.36M | 2.37% | +$4.36M |
| Autolus Therapeutics plcADS(AUTL) | 3,009,392 | 2,728,910 | -280,482 | $7.07M | $4.23M | 2.30% | -$2.84M |
| Helix Acquisition Corp IiCL A | 500,000 | 373,833 | -126,167 | $5.25M | $4.22M | 2.30% | -$1.03M |
| Zura Bio LimitedCL A(ZURA) | 3,170,194 | 3,170,194 | 0 | $7.93M | $4.09M | 2.22% | -$3.84M |
| Beam Therapeutics Inc.(BEAM) | 0 | 175,562 | +175,562 | $0 | $3.43M | 1.86% | +$3.43M |
| Arcellx Inc COMMON STOCK | 0 | 45,000 | +45,000 | $0 | $2.95M | 1.60% | +$2.95M |
| Mereo BioPharma Group plcADS(MREO) | 1,150,000 | 1,275,000 | +125,000 | $4.03M | $2.87M | 1.56% | -$1.16M |
| Context Therapeutics Inc.(CNTX) | 4,683,711 | 4,683,711 | 0 | $4.92M | $2.87M | 1.56% | -$2.05M |
| Rezolute, Inc.(RZLT) | 621,894 | 833,042 | +211,148 | $3.05M | $2.42M | 1.31% | -$631.5K |
| Centessa Pharmaceuticals PlcADS | 0 | 149,702 | +149,702 | $0 | $2.15M | 1.17% | +$2.15M |
| Voyager Therapeutics, Inc.(VYGR) | 826,751 | 626,275 | -200,476 | $4.69M | $2.12M | 1.15% | -$2.57M |
| Promis Neurosciences Inc | 2,645,128 | 2,645,128 | 0 | $2.51M | $1.84M | 1.00% | -$667.4K |
| Upstream Bio, Inc.(UPB) | 300,000 | 300,000 | 0 | $4.93M | $1.84M | 1.00% | -$3.10M |
| Pliant Therapeutics, Inc.(PLRX) | 1,055,000 | 850,000 | -205,000 | $13.89M | $1.15M | 0.62% | -$12.75M |
| Jasper Therapeutics, Inc.(JSPR) | 322,380 | 0 | -322,380 | $6.89M | $0 | — | -$6.89M |
| Optinose Inc | 370,269 | 0 | -370,269 | $2.47M | $0 | — | -$2.47M |
| Oruka Therapeutics, Inc.(ORKA) | 228,803 | 0 | -228,803 | $4.44M | $0 | — | -$4.44M |
| UroGen Pharma Ltd.(URGN) | 187,843 | 0 | -187,843 | $2.00M | $0 | — | -$2.00M |